New thigh bone nail tested for better fracture recovery

NCT ID NCT04015128

First seen Jun 24, 2026 · Last updated Jul 09, 2026 · Updated 3 times

Summary

This study looks at how well a metal nail system (T2 Alpha Femur Antegrade GT/PF Nail) works for treating broken thigh bones (femur fractures). About 66 adults will receive the nail, and their leg function will be checked after 12 months. The goal is to see if this nail helps people recover as well as older nail designs.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Femoral Nail GT of the T2 Alpha Femur Antegrade GT/PF Nailing System (a metal rod inserted into the thigh bone to stabilize fractures)
What this could lead to
If successful, this study could confirm that this nail system helps people with femur fractures regain leg function as well as or better than existing options.
What could go wrong
This is a small, non-blinded study with only 66 participants, so results may not apply to everyone. As with any surgery, risks include infection, implant failure, or slow healing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FEMORAL FRACTURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Femoral Fractures femoral neck fracture

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Inova Fairfax Medical Campus

    Falls Church, Virginia, 22042, United States

  • NYU Langone Medical Center

    New York, New York, 10016, United States

  • Regional One Health

    Memphis, Tennessee, 38103, United States

  • Reno Orthopedic Clinic

    Reno, Nevada, 89503, United States

  • St. Cloud Orthopedic Associates, Ltd

    Sartell, Minnesota, 56377, United States

  • UC Health

    Cincinnati, Ohio, 45229, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.